5 Heart Attack Clinical Trials in Fairway, KS (2026)

Q: How do I join a clinical trial in Fairway?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairway research site will contact you.

Recruiting Heart Attack Studies in Fairway

NCT03013998Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BAML-16-001-M1)."...

Fairway, KS3,000 participantsBeat AML, LLC

View Study Details

NCT06733935Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells ...

Fairway, KS240 participantsNkarta, Inc.

View Study Details

NCT05756322Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

The most common types of acute leukaemia are acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). AML is a heterogenous clonal disorder of haemopoietic progenitor cells and the most ...

Fairway, KS90 participantsLin BioScience, Inc

View Study Details

NCT06634394Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

A multi-center, open-label, dose-finding study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML....

Fairway, KS39 participantsAptevo Therapeutics

View Study Details

NCT04167696Recruiting

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

An open-label, phase I, multi-center study to determine in relapsed/refractory (r/r) acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) patients the recommended dose of CYAD-02 after a non...

Fairway, KS27 participantsCelyad Oncology SA

View Study Details

About Heart Attack Clinical Trials in Fairway

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 5 heart attack clinical trials recruiting participants in Fairway, KS. These studies are seeking a combined 3,396 participants. Research is being sponsored by Beat AML, LLC, Nkarta, Inc., Lin BioScience, Inc and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Fairway — FAQ

Are there heart attack clinical trials in Fairway?

Yes, there are 5 heart attack clinical trials currently recruiting in Fairway, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fairway?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairway research site will contact you about next steps.

Are clinical trials in Fairway free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairway studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 5 active trials in Fairway are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 13, 2026 from ClinicalTrials.gov